Androgenetic alopecia (AGA) is the most common form of hair loss, affecting 23–87% of the global population. It is driven by genetic predisposition and dihydrotestosterone, leading to hair follicle (HF) miniaturization and shortened anagen phase. Current treatments—finasteride, minoxidil, and surgical transplantation—have limited efficacy, side effects, and high costs. Exosomes, nanoscale extracellular vesicles rich in microRNAs (miRs) and growth factors, offer a promising cell-free alternative by activating hair follicle stem cells (HFSCs) and restoring hair growth.
Hair Follicle Anatomy and Stem Cell Niches
The HF is a mini-organ with distinct regions. Key components include:
Dermal papilla (DP): A mesenchymal niche at the bulb base that regulates HF cycling.
Bulge stem cells: HFSCs that remain quiescent until activated.
Adipose tissue: Surrounding DP cells, it synchronizes with HF cycles and secretes regulatory factors.
Key Signaling Pathways
Wnt/β-catenin: Master regulator of anagen induction. AGA involves downregulation via increased DKK1 and SFRP2.
Notch: Maintains stem cell function and epidermal integrity.
Sonic Hedgehog (Shh): Promotes anagen and DP maturation.
BMP: Maintains telogen quiescence; its antagonist Noggin induces anagen.
TGF-β: In AGA, dihydrotestosterone increases TGF-β, suppressing β-catenin in DP cells.
HIF-1α: Regulates angiogenesis and DP proliferation; its stimulation mimics minoxidil effects.
Exosome Composition and Key MicroRNAs
Exosomes (30–200 nm) deliver miRs, proteins, and growth factors to target cells. Key miRs in hair growth:
Pro-anagen: miR-21 (inactivates BMP4), miR-122-5p (blocks TGF-β1/SMAD3), miR-181a-5p, miR-218-5p (activate Wnt/β-catenin)
Inhibitory: miR-22, miR-29a/b, miR-133b (suppress Wnt signaling), miR-1285-3p (activates Notch, blocks HFSC proliferation)
Growth factors (VEGF, PDGF, IGF1, irisin) and neurotrophins (GDNF, BDNF) also regulate HF cycling.
Exosome Sources and Clinical Potential
Macrophage-derived exosomes: Express Wnt3a/Wnt7b on their surface, activating Wnt signaling in DP cells and doubling hair shaft thickness.
Adipose-derived stem cell exosomes (ADSC-Exos): Carry miR-122-5p, neutralize dihydrotestosterone effects, and restore anagen via Wnt activation.
Dermal papilla cell exosomes (DPC-Exos): Induce anagen via β-catenin and Shh; contain miR-218-5p and miR-181a-5p.
Bone marrow MSC exosomes: Reduce inflammation and promote regeneration (ExoFlo under development).
Umbilical cord MSC exosomes: Rich in miR-181, activate Wnt signaling.
Challenges and Future Directions
Key obstacles include lack of standardized isolation protocols, limited large-scale clinical trials, safety concerns, and unclear mechanisms of miR loading. Future priorities: standardized manufacturing, engineered exosomes with enriched therapeutic miRs, combination therapies, and rigorous clinical validation.
Conclusions
Exosome-based therapies offer a low-immunogenicity, cell-free strategy for AGA by delivering miRs and growth factors that activate HFSCs via Wnt/β-catenin, Shh, and HIF-1α pathways. While standardization and clinical validation remain challenges, robust preclinical evidence supports exosomes as a transformative approach for hair regeneration.
https://www.xiahepublishing.com/1555-3884/GE-2025-00058
The study was recently published in the Gene Expression .
Gene Expression (GE) is an open-access journal. It was launched in 1991 by Chicago Medical School Press, and transferred to Cognizant Communication Corporation in 1994. From August 2022, GE is published by Xia & He Publishing Inc.
GE publishes peer-reviewed and high-quality original articles, reviews, editorials, commentaries, and opinions on its primary research topics including cell biology, molecular biology, genes, and genetics, especially on the cellular and molecular mechanisms of human diseases.
GE has been indexed in Medline (1991-2021), Scopus, Biological Abstracts, Biosis Previews, ProQuest, etc .
Follow us on X: @xiahepublishing
Follow us on LinkedIn: Xia & He Publishing Inc.
Gene Expression
Exosome-based Therapies for Androgenetic Alopecia: Mechanisms, MicroRNAs, and Clinical Prospects
25-Mar-2026